Voyager Therapeutics Inc
NASDAQ:VYGR
Voyager Therapeutics Inc
NASDAQ:VYGR
Price:
3.685
USD
-0.41%
Market Closed
Market Cap:
$204.9m
Balance Sheet
Balance Sheet Decomposition
Voyager Therapeutics Inc
Voyager Therapeutics Inc
Balance Sheet Decomposition is not available for
Voyager Therapeutics Inc
Voyager Therapeutics Inc
Balance Sheet
Voyager Therapeutics Inc
Voyager Therapeutics Inc
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
0
|
7
|
31
|
37
|
32
|
47
|
86
|
104
|
117
|
99
|
69
|
71
|
|
| Cash Equivalents |
0
|
7
|
31
|
37
|
32
|
47
|
86
|
104
|
117
|
99
|
69
|
71
|
|
| Short-Term Investments |
0
|
0
|
163
|
138
|
138
|
109
|
196
|
77
|
15
|
20
|
162
|
195
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
19
|
8
|
1
|
1
|
84
|
4
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
19
|
8
|
1
|
0
|
83
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
2
|
|
| Other Current Assets |
0
|
1
|
1
|
4
|
3
|
7
|
4
|
9
|
3
|
5
|
4
|
6
|
|
| Total Current Assets |
0
|
8
|
196
|
179
|
172
|
163
|
305
|
198
|
137
|
125
|
320
|
277
|
|
| PP&E Net |
0
|
3
|
3
|
8
|
10
|
13
|
47
|
62
|
55
|
33
|
30
|
48
|
|
| PP&E Gross |
0
|
3
|
3
|
8
|
10
|
13
|
47
|
62
|
55
|
33
|
30
|
48
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
3
|
5
|
8
|
12
|
16
|
17
|
15
|
16
|
|
| Long-Term Investments |
0
|
0
|
30
|
1
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
66
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
2
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
3
|
|
| Total Assets |
0
N/A
|
12
+11 400%
|
230
+1 896%
|
190
-17%
|
185
-3%
|
177
-4%
|
355
+100%
|
262
-26%
|
194
-26%
|
159
-18%
|
351
+120%
|
393
+12%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
1
|
2
|
1
|
1
|
1
|
1
|
4
|
1
|
1
|
3
|
2
|
4
|
|
| Accrued Liabilities |
0
|
1
|
3
|
7
|
12
|
10
|
25
|
18
|
20
|
11
|
20
|
21
|
|
| Short-Term Debt |
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
20
|
7
|
3
|
21
|
47
|
8
|
31
|
59
|
43
|
24
|
|
| Total Current Liabilities |
4
|
3
|
24
|
14
|
16
|
32
|
76
|
27
|
51
|
73
|
65
|
50
|
|
| Long-Term Debt |
0
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
2
|
37
|
40
|
35
|
99
|
179
|
81
|
48
|
28
|
50
|
44
|
|
| Total Liabilities |
4
N/A
|
10
+158%
|
60
+486%
|
54
-11%
|
50
-6%
|
131
+159%
|
255
+95%
|
107
-58%
|
99
-8%
|
100
+2%
|
115
+15%
|
93
-19%
|
|
| Equity | |||||||||||||
| Common Stock |
0
|
22
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
21
|
50
|
90
|
161
|
269
|
313
|
276
|
347
|
394
|
261
|
326
|
|
| Additional Paid In Capital |
0
|
0
|
219
|
226
|
295
|
316
|
412
|
430
|
442
|
453
|
498
|
626
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
1
N/A
|
169
+15 273%
|
136
-20%
|
134
-1%
|
46
-65%
|
100
+114%
|
154
+55%
|
95
-38%
|
59
-38%
|
236
+301%
|
300
+27%
|
|
| Total Liabilities & Equity |
0
N/A
|
12
+11 400%
|
230
+1 896%
|
190
-17%
|
185
-3%
|
177
-4%
|
355
+100%
|
262
-26%
|
194
-26%
|
159
-18%
|
351
+120%
|
393
+12%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
26
|
26
|
26
|
26
|
32
|
32
|
37
|
37
|
38
|
39
|
44
|
55
|
|
Switch to:
Switch to:
See Also
Discover More
